Cargando…
Evaluating Johnson and Johnson COVID-19 Vaccination Outcomes in a Low-Income Hispanic Population
Background: A pilot study was performed at a low-income emergency care clinic to assess the humoral immune response to the Johnson & Johnson (J&J) COVID-19 vaccine (Ad26.COV2.S) to better understand how to evaluate the COVID-19 health status of its Hispanic patient population following vacci...
Autores principales: | Lamb, Christopher, Owens, Christopher, Gamboa, Wendy, Lopez-Yunez, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865710/ https://www.ncbi.nlm.nih.gov/pubmed/36679993 http://dx.doi.org/10.3390/vaccines11010148 |
Ejemplares similares
-
VITT REACTION ASSOCIATED WITH JOHNSON & JOHNSON COVID-19 VACCINE
por: AKUNA, MELANIE, et al.
Publicado: (2021) -
Janssen/Johnson & Johnson COVID-19 vaccine-related GBS in USA
Publicado: (2021) -
Johnson and Johnson COVID-19 Vaccination Triggering Pheochromocytoma Multisystem Crisis
por: Haji, Nahel, et al.
Publicado: (2021) -
ANCA-associated vasculitis following Johnson and Johnson COVID-19 vaccine
por: Yadav, Rukesh, et al.
Publicado: (2022) -
COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration
por: Wagner, Abram L., et al.
Publicado: (2023)